Phase II study of weekly cabazitaxel for ‘unfit’ metastatic...

Annals of Oncology 2016 / 10 Vol. 27; Iss. suppl_6

Phase II study of weekly cabazitaxel for ‘unfit’ metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel (D) treatment. Circulating tumour cell (CTC) analysis (SOGUG-CABASEM Trial)

Anido, U., Fita, M.J. Juan, Munielo-Romay, L., Pérez-Valderrama, B., Mellado, B., de Olza, M. Ochoa, Calvo, O. Fernandez, Castellano, D., Parra, E.M. Fernandez, Domenec, M., Hernando, S., Arija, J. Ar
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw372.37
Date:
October, 2016
File:
PDF, 42 KB
english, 2016
Conversion to is in progress
Conversion to is failed